Rational for the Use of Velocity-Pressure Loop in the Operating Room
VPLOOP
Cardiac Afterload Indices Measured in Ascending and Descending Aorta: Rational for the Use of Velocity-Pressure Loop in the Operating Room
1 other identifier
observational
55
0 countries
N/A
Brief Summary
In surgical patients considered with "high cardiovascular risk", by their field or by the nature of their intervention, it is recommended to use hemodynamic monitoring including a continuous measurement device of arterial pressure and cardiac output (CO). However, targeting mean arterial pressure (MAP) with boluses of selective peripheral vasopressors (without positive inotropic or chronotropic effects) could have deleterious effects on CO. Thus, it seems important to use a combined analysis of MAP and CO to estimate the afterload-related cardiac performance (ACP) The investigators recently proposed a cardiac afterload monitoring, in the descending thoracic aorta, based on a combined analysis of flow velocity signal recorded by trans-oesophageal Doppler and aortic pressure, the Velocity-Pressure Loop (VP Loop). VP Loop, and its derived indicators, especially Global AfterLoad Angle (GALA), could be useful during hemodynamic management for continuous cardiac afterload monitoring. However, in cardiology unit, cardiac afterload is usually measured at the ascending aorta behind the aortic valves. The main objective of this study is to compare VP Loop parameters build in the ascending and descending thoracic aorta according to patient cardiovascular risk factors.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2014
Typical duration for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 5, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 25, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
March 25, 2016
CompletedFirst Submitted
Initial submission to the registry
February 22, 2019
CompletedFirst Posted
Study publicly available on registry
February 25, 2019
CompletedFebruary 27, 2019
February 1, 2019
2.1 years
February 22, 2019
February 25, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Measure of aortic pressure in the ascending aorta and in the descending thoracic aorta in mmHg (PAo)
For all patients, aortic pressure will be collected at the end of the procedure during catheter withdrawal
Duration of the surgical intervention or interventional neuroradiology procedure (maximum 1 day)]
Aortic velocity in the ascending aorta in cm/s (VAasc.)
For all patients, aortic ascending velocity will be collected at the end of the procedure during catheter withdrawal
Duration of the surgical intervention or interventional neuroradiology procedure (maximum 1 day)
Aortic velocity in the descending aorta in cm/s (VAdes.)
For all patients, aortic descending velocity will be collected at the end of the procedure during catheter withdrawal
Duration of the surgical intervention or interventional neuroradiology procedure (maximum 1 day)]
Interventions
For all patients, data from trans-esophageal Doppler, trans-thoracic echocardiography (TTE) and hemodynamic data are collected at the end of the procedure. During catheter withdrawal, pressure waveforms are recorded at two predefined aortic locations: in the ascending aorta and in the descending thoracic aorta just in front of the esophageal Doppler probe.
Eligibility Criteria
Patients with scheduled an elective interventional neuroradiology procedure under general anesthesia requiring a continuous monitoring of mean arterial pressure and cardiac output.
You may qualify if:
- Patients \> 18 years scheduled an elective interventional neuroradiology procedure under general anesthesia requiring a continuous monitoring of mean arterial pressure and cardiac output.
- oral agreement obtained from each patient before anesthesia
You may not qualify if:
- age \<18 years
- an emergency procedure
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Joaquim MATEOlead
- INSERM UMR-942, Paris, Francecollaborator
- M3DISIMcollaborator
Study Officials
- PRINCIPAL INVESTIGATOR
Joaquim MATEO, MD
HLariboisière
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
February 22, 2019
First Posted
February 25, 2019
Study Start
January 5, 2014
Primary Completion
January 25, 2016
Study Completion
March 25, 2016
Last Updated
February 27, 2019
Record last verified: 2019-02